Roger S McIntyre, MD, FRCPC

Dr. Roger McIntyre is currently a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada. Dr. McIntyre is also Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada. Dr. McIntyre is also director for the Depression and Bipolar Support Alliance (DBSA) from Chicago, Illinois, USA.
 
Dr. McIntyre was named by Clarivate Analytics/Thomson Reuters in 2014, 2015, 2016, and 2017 as one of “The World’s Most Influential Scientific Minds”. This distinction is given by publishing the largest number of articles that rank among those most frequently cited by researchers globally in 21 broad fields of science and social science during the previous decade. 
 
Dr. McIntyre is involved in multiple research endeavours which primarily aim to characterize the association between mood disorders, notably cognitive function and medical comorbidity.  His works broadly aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment. 
 
Dr. McIntyre is extensively involved in medical education.  He is a highly sought-after speaker at both national and international meetings. He has received several teaching awards from the University of Toronto, Department of Psychiatry and has been a recipient of the joint Canadian Psychiatric Association (CPA) / Council of Psychiatric Continuing Education Award for the Most Outstanding Continuing Education Activity in Psychiatry in Canada.
 
Dr. McIntyre is a contributor to the Florida Best Practice Psychotherapeutic Medication Guidelines for Adults with Major Depressive Disorder and Bipolar Disorder. Dr. McIntyre was the co-chair of the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force on the Treatment of Comorbidity in Adults with Major Depressive Disorder or Bipolar Disorder and as well a contributor to the CANMAT guidelines for the treatment of Depressive Disorders and Bipolar Disorders. Dr. McIntyre has published more than 400 articles/manuscripts and has edited and/or co-edited several textbooks on mood disorders. 
 
Dr. McIntyre completed his medical degree at Dalhousie University.  He received his Psychiatry residency training and Fellowship in Psychiatric Pharmacology at the University of Toronto.
Dr. McIntyre is involved in multiple research endeavours which aim to characterize the association between mood disorders, especially cognitive function and medical comorbidity.  Broadly, his work aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment.
CNS Spectr. 2019 Aug;24(S1):84
Ragguett RM, Tamura JK, McIntyre RS
Bipolar Disord. 2019 Aug 29;:
Passos IC, Ballester P, Barros RC, Librenza-Garcia D, Mwangi B, Birmaher B, Brietzke E, Hajek T, Lopez Jaramillo C, Mansur RB, Alda M, Benno Haarman BCM, Isometsa E, Lam RW, McIntyre RS, Minuzzi L, Vedel Kessing L, Yatham LN, Duffy A, Kapczinski F
Bipolar Disord. 2019 Aug 29;:
Mansur RB, Lee Y, Subramaniapillai M, Cha DS, Brietzke E, McIntyre RS
Compr Psychiatry. 2019 Jul 24;94:152113
Subramaniapillai M, Mansur RB, Zuckerman H, Park C, Lee Y, Iacobucci M, Cao B, Ho R, Lin K, Phan L, McIntyre RS
Expert Rev Neurother. 2019 Aug 14;:1-7
Cha DS, Luo X, Ahmed J, Becirovic L, Cha RH, McIntyre RS
Curr Med Res Opin. 2019 Aug 02;:1
McIntyre RS, Prieto R, Schepman P, Yeh YC, Boucher M, Shelbaya A, Chambers R, Gao X, Pappadopulos E
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jul 25;:109720
Grigolon RB, Brietzke E, Mansur RB, Idzikowski M, Gerchman F, De Felice FG, McIntyre RS
J Affect Disord. 2019 Jul 05;257:600-606
McIntyre RS, Masand PS, Earley W, Patel M
Ther Apher Dial. 2019 Jul 21;:
Fan SS, Lin LF, Chen VC, Hsieh CW, Hsiao HP, McIntyre RS, Iacobucci M, Coles AS, Tsai DJ, Weng JC, Chen YL
Curr Med Res Opin. 2019 Jul 16;:1
McIntyre RS, Calabrese JR

Pages


 

Head, Mood Disorders Psychopharmacology Unit, UHN
Professor, Departments of Psychiatry and Pharmacology and Toxicology, University of Toronto